Inventor
DORVILLIUS MYLENE
FR5 patents
Patents
5 patentsUS10611848B2Apr 7, 2020
Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity
OGD2 PHARMA1 citations55
US11440968B2Sep 13, 2022
Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2)
OGD2 PHARMA0 citations54
US10745489B2Aug 18, 2020
Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancer
OGD2 PHARMA1 citations54
US10000575B2Jun 19, 2018
Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for cancer stem cells cancer
OGD2 PHARMA2 citations54
US10669328B2Jun 2, 2020
Human IgG1 derived antibody with pro-apoptotic activity
OGD2 PHARMA0 citations34